Data as of Sep 19
| -0.71 / -0.44%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 150.00, with a high estimate of 150.00 and a low estimate of 150.00. The median estimate represents a -5.78% decrease from the last price of 159.21.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.